-
-
ABOUT US
-
-

BLOG
Retatrutide impurity analysis
Release time:
2025-07-21
Retatrutide is a novel triple receptor agonist (GLP-1/GIP/GCGR). Its impurities refer to substances with different structures from the target molecule produced during synthesis, storage, or use, which may affect safety and stability. The main sources of impurities include:
I. Definition and Sources of Impurities
Retatrutide is a novel triple receptor agonist (GLP-1/GIP/GCGR). Its impurities refer to substances with different structures from the target molecule produced during synthesis, storage, or use, which may affect safety and stability. The main sources of impurities include:
Synthesis process: In solid-phase synthesis, incomplete amino acid condensation, removal of protecting groups, or side reactions (such as racemization) may introduce impurities.
Starting materials: Insufficient purity of raw materials or the presence of isomers (such as D-amino acids) may lead to residual impurities.
Storage conditions: High temperature, light, or oxidizing environments may cause degradation (such as peptide bond breakage, oxidation).
II. Common Impurity Types and Characteristics
Structural Modification Impurities
[Double-Phe22] Retatrutide Impurity: The 22nd phenylalanine (Phe) is repeatedly inserted, possibly due to amino acid addition errors during synthesis.
[D-Ser33] Retatrutide Impurity: The 33rd serine (Ser) undergoes epimerization, caused by chiral inversion during synthesis or degradation.
Characteristics: This type of impurity may alter receptor binding ability.
Degradation Products
Chain Scission Products: Peptide bond hydrolysis leads to molecular fragmentation, such as complete hydrolysis of asparagine (Asn) or succinimide intermediates.
Oxidized Impurities: Sulfur-containing amino acids (such as cysteine) are oxidized to form disulfide bonds or sulfonic acid derivatives.
Process-Related Impurities
Residual Solvents: Solvents used in synthesis (such as DMF, DMSO) are not completely removed.
Metal Catalysts: Residual metals such as palladium and nickel used in solid-phase synthesis.
Characteristics: Must comply with ICH guidelines (such as Q3C, Q3D) for residue requirements.
III. Impurity Control Strategy
Synthesis Process Optimization
Use raw materials and strictly control reaction conditions (temperature, pH, time).
Use orthogonal protecting group strategies to reduce side reactions, such as reducing the risk of racemization through Fmoc/tBu solid-phase synthesis.
Purification Technology
Liquid Chromatography (HPLC): Using a reversed-phase C18 column to separate the target peptide from impurities, with purity reaching over 99%.
Ion Exchange Chromatography: Separates charged impurities (such as oxidation products) based on charge differences.
Previous Page:
Next Page:
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.
These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.
These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.
These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.
Address: Model B204, B205-1, Hi-tech Capital City High-end Equipment Incubation Base, No. 23, Hangbu Road, Baiyan Science Park, Hi-Tech Zone, Hefei City
Sales Tel: 19856166839; 15705607678; 17354056623
Fax: 0551-62869631
E-mail: sales@bankpeptide.com